Quantbot Technologies LP Zynerba Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$3.27 - $4.64 $9,617 - $13,646	-2,941 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.23 - $4.3 $1,101 - $1,466	341 Added 13.12%	2,941 $9,000
Q2 2020 Aug 13, 2020	BUY	$3.31 - $6.54 $8,606 - $17,004	2,600 New	2,600 $8,000
Q1 2018 May 11, 2018	SELL	$8.49 - $13.46 $849 - $1,346	-100 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$8.69 - $14.59 $5,057 - $8,491	-582 Reduced 85.34%	100 $1,000
Q3 2017 Nov 07, 2017	BUY	$5.73 - $9.44 $3,907 - $6,438	682	682 $5,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.